Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) Plans — Dividend of $0.25

Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) announced a — dividend on Thursday, October 31st, Wall Street Journal reports. Investors of record on Friday, November 15th will be paid a dividend of 0.25 per share on Friday, November 29th. The ex-dividend date is Friday, November 15th.

Cryo-Cell International Stock Performance

Shares of CCEL stock opened at $7.27 on Friday. Cryo-Cell International has a fifty-two week low of $3.67 and a fifty-two week high of $9.50. The firm has a market capitalization of $58.60 million, a price-to-earnings ratio of 13.54 and a beta of 0.45.

Cryo-Cell International (NYSEAMERICAN:CCEL) last released its earnings results on Tuesday, October 15th. The company reported $0.13 earnings per share for the quarter, topping analysts’ consensus estimates of $0.02 by $0.11. The business had revenue of $8.07 million for the quarter. Cryo-Cell International had a negative net margin of 28.03% and a negative return on equity of 42.06%.

About Cryo-Cell International

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.